CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study

被引：0
|
作者：
Lanzo, G. [1 ]
Borghese, G. [1 ]
Arisio, R. [1 ]
Katsaros, D. [1 ]
Volante, M. [2 ]
Rapa, I. [2 ]
Benedetto, C. [1 ]
Ortolan, E. [3 ]
Funaro, A. [3 ]
机构：
[1] Univ Turin, St Anna Hosp, Dept Obstet & Gynaecol, I-10124 Turin, Italy
[2] Univ Turin, San Luigi Hosp, Dept Pathol, I-10124 Turin, Italy
[3] Univ Turin, Dept Immunogenet, I-10124 Turin, Italy
来源：
REPRODUCTIVE SCIENCES | 2014年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：208A / 209A
页数：2
相关论文
共 50 条
  • [31] Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
    Lubomir Bodnar
    Aleksandra Stanczak
    Szczepan Cierniak
    Marta Smoter
    Marzena Cichowicz
    Wojciech Kozlowski
    Cezary Szczylik
    Maciej Wieczorek
    Monika Lamparska-Przybysz
    Journal of Ovarian Research, 7
  • [32] Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
    Bodnar, Lubomir
    Stanczak, Aleksandra
    Cierniak, Szczepan
    Smoter, Marta
    Cichowicz, Marzena
    Kozlowski, Wojciech
    Szczylik, Cezary
    Wieczorek, Maciej
    Lamparska-Przybysz, Monika
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [33] Prognostic and predictive markers of ovarian cancer
    Meinhold-Heerlein, I.
    Braeutigam, K.
    Pecks, U.
    Maass, N.
    Bauerschlag, D. O.
    GYNAKOLOGE, 2013, 46 (06): : 386 - 391
  • [34] An immunohistological study of expression of BST1/CD157 in embryonic and developed mice
    Zhong, J.
    Lopatina, O.
    Higashida, C.
    Higashida, H.
    JOURNAL OF NEUROCHEMISTRY, 2012, 123 : 102 - 102
  • [35] Overview of CD24 as a new molecular marker in ovarian cancer
    Tarhriz, Vahideh
    Bandehpour, Mojgan
    Dastmalchi, Siavoush
    Ouladsahebmadarek, Elaheh
    Zarredar, Habib
    Eyvazi, Shirin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (03) : 2134 - 2142
  • [36] CD24 expression is a new prognostic marker in breast cancer
    Kristiansen, G
    Winzer, KJ
    Mayordomo, E
    Bellach, J
    Schlüns, K
    Denkert, C
    Dahl, E
    Pilarsky, C
    Altevogt, P
    Guski, H
    Dietel, M
    CLINICAL CANCER RESEARCH, 2003, 9 (13) : 4906 - 4913
  • [37] Paraneoplastic thrombocytosis as a prognostic marker in ovarian cancer
    Nakao, S.
    Matsumoto, K.
    Komiya, H.
    Tenjimbayashi, Y.
    Sakurai, M.
    Ochi, H.
    Onuki, M.
    Minaguchi, T.
    Yoshikawa, H.
    Satoh, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 791 - 791
  • [38] A novel prognostic marker in ovarian cancer.
    Kyriakopoulou, LG
    Yousef, GM
    Scorilas, A
    Katsaros, D
    Massobrio, M
    Fracchioli, S
    Diamandis, EP
    CLINICAL CHEMISTRY, 2001, 47 (06) : A132 - A132
  • [39] Evaluation of a chemoresponse assay as both a prognostic and predictive marker in the treatment of persistent or recurrent ovarian cancer
    Coleman, R.
    Sargent, D.
    Krivak, T.
    Gabrin, M.
    Brower, S.
    Tian, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S204 - S204
  • [40] Prognostic and predictive markers of ovarian cancer [Prognostische und prädiktive Marker des Ovarialkarzinoms]
    Meinhold-Heerlein I.
    Bräutigam K.
    Pecks U.
    Maass N.
    Bauerschlag D.O.
    Der Gynäkologe, 2013, 46 (6): : 386 - 391
12345